Singapore's SPRIM Global anchors $21m funding in Australia's Prota Therapeutics

Singapore's SPRIM Global anchors $21m funding in Australia's Prota Therapeutics

A technician handles a sample at a laboratory. Photographer: Anthony Kwan/Bloomberg

Mars W. Mosqueda Jr.

17 January, 2024

Edited by: Pramod Mathew

Prota Therapeutics SPRIM Global Investments

Printed by Unregistered user on Thu, 25 Dec 2025 08:48:10 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

AstraZeneca to buy China's Gracell Biotechnologies in $1.2b deal

SE Asian biotech startups get a shot in the arm post-pandemic, but road ahead ain't easy

Read more from Singapore

Asia’s secondary deals make progress after funds sell to themselves

Venture Capital

Consumer platforms DALI, CarDekho SEA eye fresh funding